Advertisement
Advertisement
U.S. markets open in 1 hour 39 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Amyris, Inc. (AMRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.3900+0.1400 (+4.31%)
At close: 04:00PM EDT
3.3500 -0.04 (-1.18%)
Pre-Market: 07:17AM EDT
Advertisement

Amyris, Inc.

5885 Hollis Street
Suite 100
EmeryVille, CA 94608
United States
510 450 0761
https://amyris.com

Sector(s)Basic Materials
IndustrySpecialty Chemicals
Full Time Employees980

Key Executives

NameTitlePayExercisedYear Born
Mr. John G. MeloPres, CEO & Director1.94MN/A1966
Mr. Hermanus KieftenbeldCFO & Chief Admin. Officer1.08MN/A1966
Mr. Eduardo AlvarezChief Operating Officer1.24MN/A1964
Ms. Nicole KelseyChief Legal Officer & Sec.623.41kN/A1967
Mr. Peter DeNardoSr. Director of Investor Relations & Corp. CommunicationsN/AN/AN/A
Ms. Christine OforiChief People OfficerN/AN/AN/A
Mr. Charles KraftSr. VP of Global Manufacturing & Process Devel.N/AN/AN/A
Ms. Caroline HadfieldPres of AprinnovaN/AN/AN/A
Mr. Jim IacoponiSr. VP of Nutrition IngredientsN/AN/AN/A
Ms. Beth Baker BannermanChief Engagement & Sustainability OfficerN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.

Corporate Governance

Amyris, Inc.’s ISS Governance QualityScore as of October 1, 2022 is 10. The pillar scores are Audit: 9; Board: 6; Shareholder Rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement